Organizations must be prepared to navigate financial challenges in an era marked by economic volatility with agility and foresight. This timely webinar explores effective crisis management strategies to help leaders and teams build resilience, maintain operational continuity, and adapt to fiscal uncertainty. Join Dr. Halligan-Avery PhD. as she shares practical strategies and actionable insights on identifying risks, protecting key resources, and fostering a culture of adaptability. Whether you’re an organizational leader or part of the management team, this session will equip you with implementable tools featured in the “Calm in Crisis: A Survival Guide for Small Nonprofits” toolkit to confidently lead through crises to maintain services to the community and retain valuable staff.

Learning Objectives

By the end of this webinar, participants will be able to:

• Describe tailored, effective communication strategies that can be implemented within an organization during a funding crisis.
• Identify proactive methods to strengthen organizational resilience before a funding crisis occurs.
• Apply practical strategies and resource-finding techniques to support organizational stability during periods of financial uncertainty.
  

Faculty

Erin Halligan-Avery, PhD
CEO and President, ConcernCenter, Inc.

---

Accreditation, Credit, and Support

This activity is certified and participants can earn up to 1.0 credits/contact hours (CME, APA, AAPA, CPE, ANCC, ASWB) for completion of the activity.

In support of improving patient care, HealthHIV is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

---

Physician Continuing Medical Education
HealthHIV designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

---

ECMEC® Credit

The European Union of Medical Specialists-European Accreditation Council for Continuing Medical Education (UEMS-EACCME®) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 Credit(s)TM into European CME credit (ECMEC®) should contact the UEMS (www.uems.eu).

---

Physician Associate Credit Designation Statement

HealthHIV has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until May 21, 2026. PAs should only claim credit commensurate with the extent of their participation.

---

Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour.

---

Continuing Pharmacy Education
HealthHIV designates this continuing education activity for 1.0 contact hour (0.1 CEU) of the Accreditation Council for Pharmacy Education.

Type of Activity: Knowledge
Please see below for UAN numbers:

• UAN JA4008396-0000-25-011-L02-P
• UAN JA4008396-0000-25-011-L02-T

---

Social Worker Continuing Education

As a Jointly Accredited Organization, HealthHIV is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. Regulatory boards have the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.0 general continuing education credit.

---

Interprofessional Continuing Education (IPCE) Statement

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

---

Planning Committee and Content/Peer Reviewers

The planners and content/peer reviewers from HealthHIV, the joint provider, do not have any relevant financial relationships to disclose with ineligible companies.

---

Disclosure & Conflict of Interest Policy

HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.

---

Disclosure of Unlabeled Use

This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to theofficial prescribing information for each product for discussion of approved indications, contraindications, and warnings.

---

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

---

Method of Participation

There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.

For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.

For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your Board Unique ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit (75% is required for ABS).

For Pharmacists, HealthHIV will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.

---

About This Activity

HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV.

The materials presented here are used with the permission of the authors and/or other sources.